First milestone successfully achieved in Ribo’s collaboration on liver diseases with Boehringer Ingelheim
Suzhou Ribo Life Science and Ribocure AB are excited to share that we have achieved a key pre-clinical milestone in our siRNA programs, less than a year into our collaboration with Boehringer Ingelheim. These achievements highlight the strength of Boehringer Ingelheim’s expertise in MASH and validate the power of the Ribo platform and organization. We […]
